Positive Psychology for Stem Cell Transplant Survivors

Positive Psychology Intervention for Hematopoietic Stem Cell Transplantation Survivors

Recruiting N/A Interventional Study
Hematopoietic Stem Cell Transplant
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Supportive Care
Participants needed
400 (estimated)
Sponsor
Brigham and Women's Hospital · Other
Who this trial is looking for

This trial is looking for adult survivors of hematopoietic stem cell transplant who are nearing 100 days after their treatment. Participants will take part in a program focusing on positive psychology to help with anxiety, depression, and overall quality of life.

Are You a Good Fit for This Trial?

You may be able to join if

  • I am an adult aged 18 or older
  • I have undergone allogeneic hematopoietic stem cell transplant
  • I am approaching 100 days post-transplant
  • I can speak, read, and respond to questions in English or Spanish
  • I have access to a basic telephone

You may not be able to join if

  • I underwent allogeneic stem cell transplant for a benign condition
  • I have severe psychiatric or cognitive conditions like dementia

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.

Check Your Eligibility
About This Trial

This randomized clinical trial is evaluating the impact of a positive psychology intervention (PATH) on anxiety symptoms, depression symptoms, and quality of life in survivors of hematopoietic stem cell transplant (HSCT) compared to usual care.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Adult patients (aged 18 years and older) undergoing allogeneic HSCT and are approaching 100-days post-HSCT * Ability to speak, read, and respond to questions in English or Spanish to complete study procedures * Access to a basic telephone Exclusion Criteria: * Patients who u…
Contacts

Hermioni Amonoo, MD, MPP, MPH

617-525-7472

hermioni_amonoo@dfci.harvard.edu

CONTACT

Isabella Larizza, BSc

ilarizza@bwh.harvard.edu

CONTACT